Posted: Jan. 24, 2020
The Delaware Thoroughbred Racing Commission Jan. 22 approved three model rules for medication reform that were recently passed by the Association of Racing Commissioners International Board of Directors.
The rules include a ban on bisphosphonates, restricting administration of non-steroidal anti-inflammatory drugs to 48 hours before a race and “stacking” of NSAIDs, and a 14-day stand down for intra-articular injections.
“All of the items were approved by the commission to move forward for the formal rule adoption process,” DTRC Executive Director John Wayne said.
The regulations will be in place when the Delaware Park meet begins in late May.
The Maryland Racing Commission in December approved the same three rules with an emergency provision that will allow them to take effect Feb. 1 at Laurel Park.
The New Jersey Racing Commission, meanwhile, has adopted the updated threshold testing levels in the ARCI Controlled Therapeutic Medication Schedule by reference.
(Delaware Park photo by Tom LaMarra)